Navigation Links
LCA-Vision Announces CEO Resignation
Date:9/18/2009

CINCINNATI, Sept. 18 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV), a leading provider of laser vision correction services under the LasikPlus(R) brand, announces that Steven C. Straus has resigned as Chief Executive Officer and a member of the company's board of directors effective September 25, 2009 to lead another healthcare company outside of the ophthalmology industry. Management of daily operations will be the responsibility of Chief Operating Officer David L. Thomas and Chief Financial Officer Michael Celebrezze, jointly reporting to the board of directors through non-Executive Chairman E. Anthony Woods.

"On behalf of the LCA-Vision board of directors, our surgeons and all employees, I would like to thank Steve for his service to our company and wish him well in his new endeavor," said Mr. Woods. "We are fortunate to have an excellent team in place companywide, and I am confident that our executives have the skills to advance our business plan and guide LCA-Vision through current macroeconomic challenges.

"The employees of LCA-Vision are fully committed to achieving success in the marketplace and, in turn, creating long-term sustainable shareholder value," he added. "Our strategic and operating plan continues to be built upon excellence in service and clinical outcomes, prudent expense management, innovative and effective marketing, advanced technology and an expanded and strengthened business model."

About LCA-Vision Inc./LasikPlus(R)

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus(R) brand, operates 71 LasikPlus(R) fixed-site laser vision correction centers in 31 states and 53 markets in the United States and a joint venture in Canada. Additional company information is available at www.lca-vision.com and www.lasikplus.com.

           Earning Trust Every Moment to Forge Lifetime Relationships.

    For Additional Information

    Company Contact:                Investor Relations Contact:
    Barb Kise                       Jody Cain
    LCA-Vision Inc.                 Lippert/Heilshorn & Associates
    513-792-9292                    310-691-7100


'/>"/>
SOURCE LCA-Vision Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. LCA-Vision Names Michael J. Celebrezze CFO
2. Shareholder Class Action Filed Against LCA-Vision, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers
4. Rigel Announces Pricing of Public Offering of 13,000,000 Shares of Common Stock
5. InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
6. Aethlon Medical, Inc. Announces Annual Meeting Results
7. Sangamo BioSciences Announces Presentation at the UBS Global Life Sciences Conference
8. Martek Announces Addition to Its Board of Directors
9. Pervasis Therapeutics Announces $17 Million in Financing and New Board Member
10. BVGH Announces New Board Chair
11. Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/27/2016)... BOSTON , June 27, 2016   Ginkgo ... biology to industrial engineering, was today awarded as ... a selection of the world,s most innovative companies. ... at scale for the real world in the ... organism engineers work directly with customers including Fortune ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica ... in people with peritoneal or pleural mesothelioma. Their findings are the subject of a ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
Breaking Biology Technology:
(Date:6/15/2016)... ALBANY, New York , June 15, 2016 ... published a new market report titled "Gesture Recognition Market ... Trends and Forecast, 2016 - 2024". According to the ... at USD 11.60 billion in 2015 and is ... and reach USD 48.56 billion by 2024.  ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:6/1/2016)... 1, 2016 Favorable Government Initiatives ... and Criminal Identification to Boost Global Biometrics System Market ... TechSci Research report, " Global Biometrics Market By ... and Opportunities, 2011 - 2021", the global biometrics market ... on account of growing security concerns across various end ...
Breaking Biology News(10 mins):